JNJ-17203212 is a selective, potent and competitive TRPV1 antagonist. JNJ-17203212 is developed for researching pain management, such as migraine[1][2].
Molecular Weight:
419.32
Purity:
99.94
CAS Number:
[821768-06-3]
Formula:
C17H15F6N5O
Target:
TRP Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted